Why we built this
We are building what we wanted on the other side of the table.
One of us spent two decades holding the P&L while somebody else’s deck landed on the desk. The other spent fifteen years producing those decks inside a global consulting firm. Both seats have the same complaint: the analysis was usually good, and it was slow, expensive, and stopped at the recommendation — which is where the work actually starts.
What changed is that procurement turns out to be one of the best things AI has ever been pointed at. Not because the technology is impressive, but because of the shape of this particular job.
You do not have to predict the future
AI is unreliable at guessing what happens next. Procurement never asks it to. What did you buy, from whom, at what price, on what terms — every question that matters has already happened.
The data is always a mess
Vendor names spelled four ways, categories nobody maintains, a ledger built for accounting rather than sourcing. Cleaning that up used to be most of the cost of a diagnostic. It is now the cheapest part.
Breadth used to be the constraint
Understanding a category across every market a company buys in was limited by how many people you could put on it, and for how long. That ceiling has moved a long way.
Judgment did not get cheaper
Which opportunity is real, which supplier relationship is load-bearing, what to do on the Tuesday after the analysis lands — still a person who has done it before. We are not automating that.
So the work that took a large team a quarter takes a small one a few weeks, and the money that went into producing the analysis goes into staying long enough to capture what it found. That is the whole company.
Who you would be working with
Jim Williamson LinkedIn
Co-Founder
Former leader of the global Product Development & Procurement practice, McKinsey & Company
Fifteen years at McKinsey, where he built many of the sourcing, design-to-value and margin-optimization methods still in use across industries. Engineer, thirteen patents.
Two decades building and leading companies that scale, clear the FDA and return capital. Full P&L ownership across multiple facilities, one revenue turnaround, and a 2023 NASDAQ IPO.
Start with one company.
Thirty minutes on one company’s spend, and we will tell you what we would expect to find and roughly what it is worth. If there is not enough there, we will say so.
No commitment, and nothing to demo. Just a conversation.